Forte Biosciences, Inc. (FBRX): Price and Financial Metrics
GET POWR RATINGS... FREE!
FBRX Stock Price Chart Interactive Chart >
FBRX Price/Volume Stats
|Current price||$1.55||52-week high||$7.26|
|Prev. close||$1.54||52-week low||$1.50|
|Day high||$1.64||Avg. volume||252,890|
|50-day MA||$2.39||Dividend yield||N/A|
|200-day MA||$4.25||Market Cap||22.87M|
Forte Biosciences, Inc. (FBRX) Company Bio
Forte Biosciences Inc. operates as a clinical-stage dermatology company in the United States. It is developing a live biotherapeutic FB-401 that has completed Phase 1/2a clinical trial to treat inflammatory skin diseases for pediatric atopic dermatitis patients. The company is based in Torrance, California.
Most Popular Stories View All
FBRX Latest News Stream
|Loading, please wait...|
FBRX Latest Social Stream
View Full FBRX Social Stream
Latest FBRX News From Around the Web
Below are the latest news stories about Forte Biosciences Inc that investors may wish to consider to help them evaluate FBRX as an investment opportunity.
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Forte Biosciences, Inc. – FBRX
NEW YORK, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Forte Biosciences, Inc. (“Forte” or the “Company”) (NASDAQ: FBRX). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Forte and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class acti
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Forte Biosciences, Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, September 08, 2021--ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Forte Biosciences, Inc.
INVESTIGATION REMINDER: The Schall Law Firm Announces It Is Investigating Claims Against Forte Biosciences, Inc. and Encourages Investors with Losses to Contact the Firm
Los Angeles, California--(Newsfile Corp. - September 6, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Forte Biosciences, Inc. ("Forte" or "the Company") (NASDAQ: FBRX) for violations of the securities laws.The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Forte announced after the market closed on
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Forte Biosciences, Inc. (FBRX) Investigation
NEW YORK, NY / ACCESSWIRE / September 3, 2021 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Forte Biosciences, Inc. ("Forte" or the "Company") (NASDAQ:FBRX).
FBRX Price Returns